Covering new weight loss drugs could strain Medicare, policy experts warn
The emergence of highly effective obesity drugs has spurred renewed efforts to get Medicare to pay for weight loss medications, but a group of health policy experts is sounding caution.
Even a small amount of uptake would create significant costs for Medicare, likely leading the federal insurer to raise premiums in the long run, the researchers said in a perspective piece Saturday in the New England Journal of Medicine.
Read Original Article: Covering new weight loss drugs could strain Medicare, policy experts warn »